Advertisement

Idiopathic Intracranial Hypertension and Optic Nerve Damage

  • Jidi Fu
  • Yunxiao Sun
Chapter
Part of the Advances in Visual Science and Eye Diseases book series (AVSED, volume 3)

Abstract

Idiopathic intracranial hypertension (IIH) is a kind of familiar disease for neurological physicians, a syndrome which takes headaches, optical disk edema, and some other signs and symptoms related to increased intracranial pressure as the main clinical manifestations, while imaging examination shows no intracranial space-occupying lesions, vascular lesions, hydrocephalus, or other related intracranial lesions, with normal cerebrospinal fluid composition. In the past, patients with IIH could only be related to ophthalmology for evaluation of optic nerve morphology and status of visual field. However, by integrating lamina cribrosa district into the whole optic nerve pathways by ophthalmologists, people gradually realize that the cerebrospinal fluid circulation around the optic nerve is also related to the eye disease, such as glaucoma. It may provide a good control model for the study of glaucoma. We hope that this chapter, on the one hand, can make eye doctor know more about IIH, including the historical evolution, epidemiology, pathogenesis, clinical manifestation, standard diagnosis, and treatment of this disease; on the other hand, we hope to inspire the reader to recognize the eye diseases from the perspective of craniocerebral diseases.

References

  1. 1.
    Quincke H. Meningitis serosa. Sammlung klinischer Vortrage Innere Medizin. 1893;67:655.Google Scholar
  2. 2.
    Nonne M. Uber Falle vom Symtomkomplex “Tumor Cerebri” mit Ausgang in Heilung “Pseudotumor Cerebri”. Deutsch Z Nervenheilkunde. 1904;27:169–216.CrossRefGoogle Scholar
  3. 3.
    Symonds CP. Otitic hydrocephalus. Brain. 1931;54:55–71.CrossRefGoogle Scholar
  4. 4.
    Dandy WE. Intracranial pressure without brain tumor: diagnosis and treatment. Ann Surg. 1937;106:492–513.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Foley J. Benign forms of intracranial hypertension: “toxic” and “otitic” hydrocephalus. Brain. 1955;78:1–41.CrossRefPubMedGoogle Scholar
  6. 6.
    Buchheit WA, Burton C. Nomenclature in intracranial pressure. N Engl J Med. 1969;281(1):47.CrossRefPubMedGoogle Scholar
  7. 7.
    Buchheit WA, Burton C, Haag B, Shaw D. Papilledema and idiopathic intracranial hypertension. N Engl J Med. 1969;280(17):938–42.CrossRefPubMedGoogle Scholar
  8. 8.
    Corbett JJ, Thompson HS. The rational management of idiopathic intracranial hypertension. Arch Neurol. 1989;46:1049–51.CrossRefPubMedGoogle Scholar
  9. 9.
    Smith JL. Whence pseudotumor cerebri? J Clin Neuroophthalmol. 1985;5:55–6.PubMedGoogle Scholar
  10. 10.
    Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59:1492–5.CrossRefPubMedGoogle Scholar
  11. 11.
    Friedman DI. The pseudotumor cerebri syndrome. Neurol Clin. 2014;32:363–96.CrossRefPubMedGoogle Scholar
  12. 12.
    Wakerley B, Tan M, Ting E. Idiopathic intracranial hypertension. Cephalalgia. 2015;35(3):248–61.CrossRefPubMedGoogle Scholar
  13. 13.
    Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain. 1991;114:155–80.CrossRefPubMedGoogle Scholar
  14. 14.
    Kupersmith MJ, Gamell L, Turbin R, et al. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology. 1998;50:1094–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Tomsak RL, Niffenegger AS, Remler BF. Treatment of pseudotumor cerebri with Diamox (acetazolamide). J Clin Neuroophthalmol. 1988;18:93–8.Google Scholar
  16. 16.
    Celebisoy N, Gökc a F, Sirin H, et al. Treatment of idiopathic intracranial hypertension: Topiramate vs. acetazolamide, an open-label study. Acta Neurol Scand. 2007;116:322–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Schoeman JF. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. J Child Neurol. 1994;9:130–4.CrossRefPubMedGoogle Scholar
  18. 18.
    Liu GT, Glaser JS, Schatz N. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am J Ophthalmol. 1994;118:88–96.CrossRefPubMedGoogle Scholar
  19. 19.
    Fridley J, Foroozan R, Sherman V, et al. Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg. 2011;114:34–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology. 1997;49:734–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Sinclair AJ, Kuruvath S, Sen D, et al. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia. 2011;31:1627–33.CrossRefPubMedGoogle Scholar
  22. 22.
    Banta JT, Farris BK. Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology. 2000;107:1907–12.CrossRefPubMedGoogle Scholar
  23. 23.
    Spoor TC, McHenry JG. Long-term effectiveness of optic nerve sheath decompression for Pseudotumor cerebri. Arch Ophthalmol. 1993;111:632–5.CrossRefPubMedGoogle Scholar
  24. 24.
    Bateman GA, Stevens SA, Stimpson J. A mathematical model of idiopathic intracranial hypertension incorporating increased arterial inflow and variable venous outflow collapsibility. J Neurosurg. 2009;110:446–56.CrossRefPubMedGoogle Scholar
  25. 25.
    Higgins JN, Cousins C, Owler BK, et al. Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting. J Neurol Neurosurg Psychiatry. 2003;74:1662–6.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Donnet A, Metellus P, Levrier O, et al. Endovascular treatment of idiopathic intracranial hypertension: clinical and radiologic outcome of 10 consecutive patients. Neurology. 2008;70:641–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China 2020

Authors and Affiliations

  • Jidi Fu
    • 1
  • Yunxiao Sun
    • 2
    • 3
    • 4
    • 5
  1. 1.Department of Neurosurgery, Beijing Tongren HosptialCapital Medical UniversityBeijingChina
  2. 2.Beijing Institute of OphthalmologyBeijingChina
  3. 3.Beijing Tongren Eye CenterBeijingChina
  4. 4.Beijing Tongren HospitalCapital Medical UniversityBeijingChina
  5. 5.Beijing Ophthalmology and Visual Sciences Key LaboratoryBeijingChina

Personalised recommendations